EventsThe 1st International Online Conference on Diagnostics
Published
This submission belongs to the session S2. Pathology and Molecular Diagnostics of the event The 1st International Online Conference on Diagnostics
Published date
18 Sep, 2026
Academic Editor
author-avatarGiorgio Treglia
Citation
Ekaterina Sorokina, Ekaterina Chernevskaya, Microbiota-Oriented Management in Chronic Critical Illness, in Proceedings of The 1st International Online Conference on Diagnostics, 23 September–24 September 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Microbiota-Oriented Management in Chronic Critical Illness

1. Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, 10703 Moscow, Russia
Abstract

Chronic critical illness is increasingly recognized as a state in which disruption of the intestinal microbiome may fuel ongoing inflammation and infection. This prospective single‑centre pilot study explored whether a structured microbiome‑oriented management strategy, guided by an integrated microbiota dysfunction score, is feasible, safe, and potentially beneficial in these patients.

Adult ICU patients meeting criteria for chronic critical illness were evaluated using a 0–12‑point Microbiota Dysfunction Degree that combined prior antibiotic exposure, systemic inflammation markers, organ failure assessment, and quantitative microbiological data from the gut. Patients were assigned to mild, moderate, or severe dysfunction categories, which determined a tiered intervention: metabiotic support alone, addition of selective enteral antimicrobials, or a combined gut‑directed and systemic antimicrobial approach designed to limit further damage to commensal anaerobes.

Forty‑three patients were enrolled, with approximately half classified as having mild microbiota dysfunction and the remainder split between moderate and severe categories. Over 14 days of follow‑up, de‑escalation of antimicrobial pressure in those with mild–moderate dysfunction did not lead to clinical deterioration, while improvements were documented in consciousness level, inflammatory indices, and several routine laboratory parameters. Opportunistic Gram‑negative pathogens were common at baseline, but the proportion of samples exceeding reference thresholds for key species, including Klebsiella pneumoniae and Clostridium spp., declined during observation. Across 28 days, the rate of pneumonia was lower than expected for this high‑risk population.

These findings indicate that a graded microbiome‑oriented strategy, anchored in a composite microbiota dysfunction score, can be implemented safely in chronically critically ill patients and may contribute to better infection control and clinical stabilization.

Keywords
chronic critical illness
gut microbiota
microbiome-oriented therapy
microbiota dysfunction score
metabiotics
selective decontamination
Design and Development of a Self-Adaptive, Multi-Modal Artificial Intelligence Framework Integrating Explainable Deep Learning, Federated Data Systems, and Geospatial Intelligence for Real-Time Precision Diagnostics in Resource-Constrained Environments
Predictors of Arrhythmias Following the Dor Procedure in Patients with Left Ventricular Aneurysms